<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The third edition of the International Classification of Diseases for <z:hpo ids='HP_0002664'>Oncology</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>-O-3), which was published in 2000, introduced major changes in coding and classification of <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, notably for <z:hpo ids='HP_0001909'>leukemias</z:hpo> and <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, which are important groups of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types that occur in childhood </plain></SENT>
<SENT sid="1" pm="."><plain>This necessitated a third revision of the 1996 International Classification of <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">Childhood Cancer</z:e> (ICCC-3) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> categories for the ICCC-3 were designed to respect several principles: agreement with current international standards, integration of the entities defined by newly developed diagnostic techniques, continuity with previous childhood classifications, and exhaustiveness </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The ICCC-3 classifies <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> coded according to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>-O-3 into 12 main groups, which are split further into 47 subgroups </plain></SENT>
<SENT sid="4" pm="."><plain>These 2 levels of the ICCC-3 allow standardized comparisons of the broad categories of childhood <z:hpo ids='HP_0002664'>neoplasms</z:hpo> in continuity with the previous classifications </plain></SENT>
<SENT sid="5" pm="."><plain>The 16 most <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> subgroups are broken down further into 2-11 divisions to allow study of important entities or homogeneous collections of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> characterized at the cytogenetic or molecular level </plain></SENT>
<SENT sid="6" pm="."><plain>Some divisions may be combined across the higher-level categories, such as the B-cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo> within <z:hpo ids='HP_0001909'>leukemias</z:hpo> and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The ICCC-3 respects currently existing international standards and was designed for use in international, population-based, epidemiological studies and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries </plain></SENT>
<SENT sid="8" pm="."><plain>The use of an international classification system is especially important in the field of pediatric <z:hpo ids='HP_0002664'>oncology</z:hpo>, in which the low frequency of cases requires rigorous procedures to ensure data comparability </plain></SENT>
</text></document>